This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Magdalena Schlager
Introduction
Magdalena Schlager is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of medical diagnostics, particularly in the measurement of Factor XIa. Her innovative work has led to the development of a unique assay that is crucial for various clinical applications.
Latest Patents
Magdalena Schlager holds a patent for a "Heparin-insensitive assay for factor XIa." This invention provides a method for measuring the concentration of Factor XIa in a plasma sample by utilizing enzymatic heparin degradation as a sample pretreatment step. This advancement is vital for improving the accuracy of diagnostic tests related to blood coagulation.
Career Highlights
She is currently associated with Takeda Pharmaceutical Company Limited, where she continues to work on innovative solutions in the pharmaceutical industry. Her expertise in the field has positioned her as a valuable asset to her team and the broader medical community.
Collaborations
Throughout her career, Magdalena has collaborated with notable colleagues, including Herbert Gritsch and Alfred Weber. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking medical technologies.
Conclusion
Magdalena Schlager's contributions to medical diagnostics through her innovative patent demonstrate her commitment to advancing healthcare solutions. Her work continues to impact the field positively, showcasing the importance of innovation in medicine.